Your browser doesn't support javascript.
loading
Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas.
Capdevila, Jaume; Arqués, Oriol; Hernández Mora, Jose Ramón; Matito, Judit; Caratù, Ginevra; Mancuso, Francesco M; Landolfi, Stefania; Barriuso, Jorge; Jimenez-Fonseca, Paula; Lopez Lopez, Carlos; Garcia-Carbonero, Rocio; Hernando, Jorge; Matos, Ignacio; Paolo, Nuciforo; Hernández-Losa, Javier; Esteller, Manel; Martínez-Cardús, Anna; Tabernero, Josep; Vivancos, Ana; Palmer, Héctor G.
Afiliación
  • Capdevila J; Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona (UAB), CIBERONC, Barcelona, Spain.
  • Arqués O; Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), CIBERONC, Barcelona, Spain.
  • Hernández Mora JR; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Matito J; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Caratù G; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Mancuso FM; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Landolfi S; Department of Pathology, Vall d'Hebron University Hospital (HUVH), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
  • Barriuso J; Department of Medical Oncology, European Neuroendocrine Tumor Society (ENETS) Centre of Excellence, The Christie NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Jimenez-Fonseca P; Department of Medical Oncology, Central de Asturias University Hospital, Oviedo, Spain.
  • Lopez Lopez C; Department of Medical Oncology, Marques de Valdecilla University Hospital, Santander, Spain.
  • Garcia-Carbonero R; Department of Medical Oncology, Doce de Octubre University Hospital, Instituto de Investigacion Hospital 12 de Octubre (i+12), Centro Nacional de Investigacion Oncologica (CNIO), CIBERONC, Universidad Complutense de Madrid (UCM), Madrid, Spain.
  • Hernando J; Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona (UAB), CIBERONC, Barcelona, Spain.
  • Matos I; Early Clinical Drug Development Group, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Paolo N; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Hernández-Losa J; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Esteller M; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Martínez-Cardús A; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Tabernero J; Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona (UAB), CIBERONC, Barcelona, Spain.
  • Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. hgpalmer@vhio.net avivancos@vhio.net.
  • Palmer HG; Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), CIBERONC, Barcelona, Spain. hgpalmer@vhio.net avivancos@vhio.net.
Clin Cancer Res ; 26(4): 902-909, 2020 02 15.
Article en En | MEDLINE | ID: mdl-31672771

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Colon / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Colon / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos